Victory Capital Management Inc Oncocyte Corp Transaction History

Victory Capital Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$0.2 - $0.35 $918 - $1,607	4,592 Added 38.82%	16,422 $3,000
Q1 2023 May 02, 2023	SELL	$0.2 - $0.49 $137 - $337	-689 Reduced 5.5%	11,830 $4,000
Q4 2022 Feb 09, 2023	SELL	$0.25 - $15.6 $1 - $62	-4 Reduced 0.03%	12,519 $4,000
Q3 2022 Nov 02, 2022	SELL	$0.76 - $15.98 $1,997 - $41,995	-2,628 Reduced 17.35%	12,523 $9,000
Q2 2022 Aug 01, 2022	SELL	$0.86 - $1.53 $211 - $376	-246 Reduced 1.6%	15,151 $14,000
Q1 2022 May 04, 2022	BUY	$1.15 - $2.25 $3,202 - $6,266	2,785 Added 22.08%	15,397 $18,000
Q4 2021 Feb 07, 2022	SELL	$2.04 - $3.59 $614 - $1,080	-301 Reduced 2.33%	12,612 $27,000
Q3 2021 Nov 02, 2021	BUY	$3.53 - $5.89 $1,111 - $1,855	315 Added 2.5%	12,913 $46,000
Q2 2021 Aug 03, 2021	SELL	$3.77 - $6.0 $2,831 - $4,506	-751 Reduced 5.63%	12,598 $72,000
Q1 2021 May 04, 2021	BUY	$2.39 - $6.5 $31,904 - $86,768	13,349 New	13,349 $69,000
Q2 2020 Aug 07, 2020	SELL	$1.91 - $3.45 $16,471 - $29,752	-8,624 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$1.76 - $3.02 $1,664 - $2,856	946 Added 12.32%	8,624 $21,000
Q4 2019 Feb 04, 2020	BUY	$1.51 - $2.27 $2,832 - $4,258	1,876 Added 32.33%	7,678 $20,000
Q3 2019 Nov 12, 2019	BUY	$1.59 - $2.51 $9,225 - $14,563	5,802 New	5,802 $12,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $246M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.